These findings highlight a dual role of HGF, released by both ASCs and breast cancer cells: First it acts as a chemoattractant to recruit different cell types (epithelial cells, endothelial progenitors, fibroblasts and immune cells), creating an inflammatory microenviroment, which sustains cancer cells growth. Here, HGF is linked to cancer.